Shanghai Biotree Biomedical Technology Co., Ltd.
PrivateLast Round
Series A
Extension
Jan 3, 2023
Total Funding Raised
$16.29M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Shanghai Biotree Biomedical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A Extension round in January 2023.
Shanghai Biotree Biomedical Technology Co., Ltd. is a biotechnology company that provides comprehensive metabolomics, proteomics, and multi-omics testing and analysis services for universities, research institutions, hospitals, and pharmaceutical enterprises.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Biotree Biomedical Technology Co., Ltd. Comparables
Compare Shanghai Biotree Biomedical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Bioprofile Technology Co., Ltd. | 93% | |
| Shanghai Applied Protein Technology Co., Ltd. | 92% | |
| Metabo-Profile Biotechnology (Shanghai) Co., Ltd. | 89% |
For institutional investors. Book with your work email.
Shanghai Biotree Biomedical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 3, 2023 | ||||
| Series A | Jul 15, 2022 | ||||
| Pre Seed | May 1, 2021 | ||||
| Angel | Aug 1, 2018 |
For institutional investors. Book with your work email.
Shanghai Biotree Biomedical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiming Venture Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased from 0 to 11, representing 122% of headcount.
- Feb 24, 2025
Grew 125% QoQ, from 4 to 9 employees.
For institutional investors. Book with your work email.
Shanghai Biotree Biomedical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Biotree Biomedical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Biotree Biomedical Technology Co., Ltd. a public or private company?
Shanghai Biotree Biomedical Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Biotree Biomedical Technology Co., Ltd.?
Shanghai Biotree Biomedical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Biotree Biomedical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Biotree Biomedical Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Biotree Biomedical Technology Co., Ltd. is not publicly available.
Can I buy Shanghai Biotree Biomedical Technology Co., Ltd. stock?
Shanghai Biotree Biomedical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Biotree Biomedical Technology Co., Ltd.'s last funding round?
Shanghai Biotree Biomedical Technology Co., Ltd.'s most recent funding round was Series A Extension on January 3, 2023.
Who are the main investors in Shanghai Biotree Biomedical Technology Co., Ltd.?
Key investors in Shanghai Biotree Biomedical Technology Co., Ltd. include Qiming Venture Partners.
Will Shanghai Biotree Biomedical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Biotree Biomedical Technology Co., Ltd..
How can I track Shanghai Biotree Biomedical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Biotree Biomedical Technology Co., Ltd.'s shares on secondary markets.